Beauty Health (NASDAQ:SKIN) Receives “Hold” Rating from Canaccord Genuity Group

Canaccord Genuity Group restated their hold rating on shares of Beauty Health (NASDAQ:SKIN) in a research note issued to investors on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a $1.50 price objective on the stock.

A number of other brokerages also recently issued reports on SKIN. Zacks Research downgraded shares of Beauty Health from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 21st. Jefferies Financial Group reissued a “hold” rating and set a $1.60 price objective on shares of Beauty Health in a report on Wednesday, January 14th. Benchmark restated a “hold” rating on shares of Beauty Health in a research report on Friday. Finally, TD Cowen raised their target price on shares of Beauty Health from $1.50 to $1.65 and gave the stock a “hold” rating in a report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Beauty Health currently has an average rating of “Reduce” and a consensus price target of $2.45.

Beauty Health Stock Up 19.8%

SKIN stock opened at $1.27 on Friday. The stock has a market capitalization of $161.93 million, a P/E ratio of -6.35 and a beta of 1.20. The company has a debt-to-equity ratio of 5.53, a current ratio of 4.98 and a quick ratio of 4.07. Beauty Health has a 1-year low of $0.78 and a 1-year high of $2.69. The business has a fifty day moving average price of $1.27 and a 200-day moving average price of $1.52.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings data on Thursday, March 12th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.01. Beauty Health had a negative return on equity of 15.35% and a negative net margin of 3.16%.The company had revenue of $82.37 million for the quarter, compared to analysts’ expectations of $78.07 million. Equities analysts forecast that Beauty Health will post -0.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Public Employees Retirement System of Ohio bought a new position in shares of Beauty Health in the 3rd quarter worth approximately $26,000. Atom Investors LP bought a new stake in Beauty Health during the fourth quarter valued at approximately $29,000. CWM LLC increased its holdings in Beauty Health by 232.8% during the fourth quarter. CWM LLC now owns 22,018 shares of the company’s stock valued at $31,000 after buying an additional 15,402 shares during the last quarter. Franklin Resources Inc. purchased a new stake in Beauty Health during the third quarter valued at approximately $31,000. Finally, Ieq Capital LLC bought a new position in Beauty Health in the fourth quarter worth approximately $33,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

More Beauty Health News

Here are the key news stories impacting Beauty Health this week:

• Positive Sentiment: Q4 results topped consensus on both revenue and EPS — revenue of ~$82.4M beat estimates and EPS of ($0.06) came in slightly better than the consensus loss. That beat helped lift sentiment after the print. Press Release
• Positive Sentiment: Analyst coverage: Canaccord reaffirmed a Hold and set a $1.50 price target — the reminder of analyst support and a PT above the current price provides incremental upside narrative for traders. Canaccord / Coverage Note
• Neutral Sentiment: Company outlined a 2026 revenue target of $285M–$305M and emphasized installed‑base utilization and product innovation as growth drivers — the plan signals a path to growth but the top‑line target is only roughly in line with Street expectations. Revenue Target Article
• Neutral Sentiment: Full earnings call and transcript are available for investors who want detail on margin dynamics, installed base metrics and management guidance assumptions. Useful if you trade around guidance cadence. Earnings Call Transcript
• Negative Sentiment: Q1 2026 revenue guidance was set at $63M–$68M, below the consensus ~ $68.6M — this softer near‑term guide may pressure sentiment if investors were expecting a stronger seasonal ramp. Guidance in Press Release
• Negative Sentiment: Profitability and balance-sheet items remain a concern: the company recorded a small net loss, operating profit was negligible, and cash & cash equivalents declined year‑over‑year — these metrics limit runway visibility until growth accelerates. Financial Highlights / QuiverQuant

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.